Home  |  About Us   |   Be Our Speaker  |  Terms & Conditions  |  Connect With Us
Executive Education
Clariden Leadership Institute
Precision Medicine Masterclass (Sydney)
Dr. Quin Wills
Genomics Head at Major Research Hub
Dr. Quin Wills, Genomics Head at Major Research Hub

 

  • Over ten years of research experience in Drug Discovery Genomics & Precision Medicine
  • Head of Advanced Genomics, Novo Nordisk Research Centre Oxford who lectures extensively on multi-scale biology, statistics for genomics and biological data analysis and informatics
  • Previously Co-Steer the Oxford University Single Cell Biology Consortium
  • Seasoned presenter and supervisor in Experimental, Computational and Translational Genomic Science

 

Dr Quin Wills is an experienced genomicist at the interdisciplinary interface of cellular genetics, with qualifications in medicine, mathematics, computational biology, and statistical genomics. Having previously co-founded a drug genomics CRO, and now leading a target discovery department, he has experience in both experimental, computational, and translational genomic science in the precision medicine space. Quin has taught a wide range of international courses in genomics and bioinformatics.

 

In addition to developing and supervising genomic software, Quin developed and lectured a series of R-based courses from exploratory data visualisation through to high throughput techniques and performance computing, aimed at multidisciplinary researchers.

 

Others: Developed and taught a workshop in `multi-scale biology', University of British Columbia. Taught `statistics for genomics', MIT. Co-developed and taught `introductory metabonomics' workshop at the Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences. Guest seminars on computational biology at the Cambridge Computational Biology Institute. Conceived and led `biological data analysis and informatics' workshop at the University of the Witwatersrand, South Africa. I've also consulted for the South African regional innovation agency on the development of a national competitive bioinformatics strategy.

Program Summary

 

Led by Dr. Quin Wills, the Genomics Head of a Major Research Hub, Dr. Wills will show you current and future applications of genomics and precision medicine at each stage and how precision & genomic medicine is changing the whole healthcare ecosystem in preventing, diagnosing and treating diseases. You will discover how genomic information is changing clinical decision-making, and some of the common pitfalls – technical and ethical – that might complicate the delivery of quality genomic healthcare.

 

Dr. Wills will also give you an overview of the major ‘translational events’ in genomic and personalized medicine, lessons learnt and how genomic medicine can be applied across a wide array of use cases – including cancer, cardiovascular, neurodegenerative, infectious disease, pain, immunology and rare diseases. Finally, you will learn how genomic medicine, together with CRISPR and next generation sequencing technologies can be incorporated into daily clinical practice to dramatically improve patient diagnosis, treatment and care.



Programs, dates and locations are subject to change. In accordance with Clariden Global policy, we do not discriminate against any person on the basis of race, color, sex, religion, age, national or disability in admission to our programs.

Introduction

 

The Precision Medicine Initiative (PMI), a research project introduced by former US President Barack Obama in his State of the Union Address on 30 January 2015 has revolutionized the way we improve health and treat diseases. Using this innovative approach that takes into account people's genes, environments and lifestyles factors, Precision Medicine gives rise to the development of personalized, tailored treatments that are as unique as our own body.

 

Led by an experience genomicist with qualifications in Clinical Medicine, Mathematics, Computational Biology, and Statistical Genomics, Dr. Quin Wills will guide you through the most recent developments in Precision Medicine, with special interest in Clinical Practice, Ethics, Emerging Business of Data-Driven and Genomic Medicine.

 

By the end of this 2-day executive program, you can expect to come away with a basic knowledge of the science, emerging trends and also ethical implications to be better equipped in your genomics research and leadership roles.

What You Can Expect

 

By the end of this program, participants will be able to:

 

  • Gain deep insight in understanding the Impacts Of Genomic Medicine in the practice of medicine
  • Understand the basics of Clinical Genetics, Next Generation Sequencing Technology & CRISPR
  • Translate Novel Discoveries into Potential Therapeutic Opportunities - Pharmacogenomics & Drug Development
  • Understand the Ethical Challenges in Applying Precision Medicine
  • Understand the use cases of Genomic Medicine in shaping the future of healthcare in Cancer Care, Diabetes & Cardiovascular Diseases

Who Will Benefit Most

 

This highly interactive program is designed for Executives, Managers, Directors, Head of Departments, Project Leaders, Senior Researchers in, but not limited to, genomic medicine, precision medtech, medical informatics, biomedical technologies, personalised therapeutics, as well as practitioners who are involved in pharmacy & experimental pharmacology, clinical and translational research, business development and marketing of the genomic-related organization.

Program Outline

 

DAY 1

09:00 – 17:00 / 20 FEBRUARY 2018

 

Comprehensive Overview of Genomic Medicine

  • The core concepts from Genes to Epigenetics
  • The different types of human variation, how this leads to disease and varying therapeutic response
  • Current clinical practise and interpreting genetic risk 

 

Genomics Technologies Primer

  • Next-Generation Sequencing (NGS) and Initiatives (e.g. the 100,000 Genomes Project)
  • Gene Editing Technologies (e.g. CRISPR)
  • High resolution genomics and initiatives (e.g. Human Cell Atlas) 

 

Precision and Digital Medicine 

  • Emerging "Big Data" Consumer Health Care Models
  • Opportunities and Commercial Offerings
  • Case Study: Can your mobile phone predict more about you than your DNA?

 

DAY 2

09:00 – 17:00 / 21 FEBRUARY 2018

 

Pharmacogenomics and Drug Development 

  • Disease and therapy biomarkers
  • Case Study: Cancer Stratification
  • Case Study: Diabetes and Cardiovascular Disease

 

The Future of Precision Medicine

  • The ROI in Precision Medicine & Genome Editing
  • Ethical Concerns
  • Case Study: What is Big Pharma investing in now?

CFOs Leadership :
Experience Clariden
Discover how our leadership program has shaped the perspectives of CFOs across Asia
 
Venue: InterContinental Sydney, Australia
Date: 20 - 21 February 2018
Faculty: Dr. Quin Wills
Early Bird 1: AU$1,795 (by 27 Dec 2017)
Early Bird 2: AU$1,995 (by 24 Jan 2018)
Regular Fee: AU$2,195
Group Discount: 2nd participant get 10%, or register 3 participants and 4th participant get a complimentary seat
(1 discount scheme applies)
Contact: kevin@claridenglobal.org
 
 
More Programs
Identifying Strategic Acquisitions and Structuring Successful M&A Deals (Singapore)
- Thomas Kessler
M&A Financial Modeling (Singapore)
- Thomas Kessler
Reinventing Organizational Design and Structure: Optimizing Strategy, People, Processes, Accountabilities and Functions (Zurich)
- Paul Gustavson
Implementing and Managing Preventive and Predictive Maintenance (Melbourne)
- Peter Ormond
HR Analytics, Metrics and Measurement (Zurich)
- Jon Ingham
View All Programs >
 
 
   
Home | About Us | Be Our Speaker | Press Release | Terms & Conditions | Connect With Us
Copyright © 2011 Clariden Global, all rights reserved.